Filing Details

Accession Number:
0001209191-21-054828
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-03 17:23:19
Reporting Period:
2021-09-01
Accepted Time:
2021-09-03 17:23:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1107421 Ziopharm Oncology Inc ZIOP Pharmaceutical Preparations (2834) 841475642
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1846984 Holger Weis C/O Ziopharm Oncology, Inc.
One First Avenue, Parris Bldg 34
Boston MA 02129
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-09-01 50,000 $1.83 120,167 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 19,000 Indirect By spouse
Common Stock 1,000 Indirect By child
Common Stock 1,240 Indirect By child
Common Stock 200 Indirect By child
Footnotes
  1. Includes 30,000 shares held in a joint account by the Reporting Person and his spouse.